Literature DB >> 20298161

Liver cancer stem cells as an important target in liver cancer therapies.

Gang-Ming Zou1.   

Abstract

Hepatic cancer is one of most common cause of cancer-related death. Hepato-epithelial cancers are believed to originate from the malignant transformation of liver-resident stem/progenitor cells. Liver cancer stem cells have been characterized recently and the phenotype of liver cancer stem cells has been defined as CD133+ CD44+ cancer cells. Recently, it has been also demonstrated about the relevance of targeting liver cancer stem cells, due to cancer stem cells are related to cancer metastasis. These advances no doubt to bring the new strategy in liver cancer treatment and control in this disease. This review describes the current status and progress about cancer stem cell research in liver and discuss of the implications of these studies in new liver cancer treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20298161     DOI: 10.2174/187152010790909263

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  4 in total

Review 1.  Stem Cell Differentiation Stage Factors from Zebrafish Embryo: A Novel Strategy to Modulate the Fate of Normal and Pathological Human (Stem) Cells.

Authors:  Pier M Biava; Silvia Canaider; Federica Facchin; Eva Bianconi; Liza Ljungberg; Domenico Rotilio; Fabio Burigana; Carlo Ventura
Journal:  Curr Pharm Biotechnol       Date:  2015       Impact factor: 2.837

2.  Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.

Authors:  Xin Zhao; Xiaoliang Liu; Guanjun Wang; Xue Wen; Xiaoying Zhang; Andrew R Hoffman; Wei Li; Ji-Fan Hu; Jiuwei Cui
Journal:  Oncotarget       Date:  2016-08-09

3.  Evaluation of the selective toxic effect of the charge switchable diethyldithiocarbamate-loaded nanoparticles between hepatic normal and cancerous cells.

Authors:  Marwa M Abu-Serie
Journal:  Sci Rep       Date:  2018-03-15       Impact factor: 4.379

4.  2-Ethoxystypandrone, a novel small-molecule STAT3 signaling inhibitor from Polygonum cuspidatum, inhibits cell growth and induces apoptosis of HCC cells and HCC Cancer stem cells.

Authors:  Wuguo Li; Qing Zhang; Kaotan Chen; Zhenhua Sima; Jingli Liu; Qiang Yu; Jiawei Liu
Journal:  BMC Complement Altern Med       Date:  2019-02-01       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.